Add Company
Join Now

LumaCyte Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • LumaCyte's estimated annual revenue is currently $3.7M per year.(i)
  • LumaCyte's estimated revenue per employee is $155,000

Employee Data

  • LumaCyte has 24 Employees.(i)
  • LumaCyte grew their employee count by -27% last year.

LumaCyte's People

NameTitleEmail/Phone
1
CEO & Chief Scientific OfficerReveal Email/Phone
2
President & Chief Business OfficerReveal Email/Phone
3
SVP, Scientific and Business OperationsReveal Email/Phone
4
Director, Enterprise Strategy Program ManagementReveal Email/Phone
5
Director Software EngineeringReveal Email/Phone
6
Director, Instrumentation R&D / EngineeringReveal Email/Phone
7
Director Application SciencesReveal Email/Phone
8
Executive Director, Business Development – EuropeReveal Email/Phone
9
Logistics & Operations ManagerReveal Email/Phone
10
Senior Biomedical EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3M393%$28.3MN/A
#2
$1.4M9-18%N/AN/A
#3
$5.3M343%N/AN/A
#4
$31.9M2060%N/AN/A
#5
$0.6M4-43%N/AN/A
#6
$4.3M55-52%$56.5MN/A
#7
$0.3M20%N/AN/A
#8
$5.4M3521%N/AN/A
#9
$1.9M120%N/AN/A
#10
$2.6M34-11%$9.8MN/A
Add Company

What Is LumaCyte?

LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis and sorting instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary technology utilizes Laser Force Cytologyâ„¢ (LFCâ„¢) to measure optical and fluidic forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell. The multivariate nature of the data has enabled a host of Big Data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell based biological systems. Applications of LumaCyte's label-free platform technology include viral infectivity for vaccine development and manufacturing, cell and gene therapy development and production monitoring, cancer biology R&D, CAR T-cell immunotherapy, iPSCs, infectious disease, and pre-clinical drug discovery, in addition to multiple applications across the biomanufacturing sector for quality control and process optimization. Innovate. Discover. Transform.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$3.7M

Revenue (est)

-27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.5M2426%N/A
#2
$3.7M24-29%N/A
#3
$3.5M24-8%N/A
#4
$5.4M24-14%N/A
#5
$4.9M2414%N/A